Track topics on Twitter Track topics that are important to you
CHICAGO — Liquid biopsy identified genomic alterations in patients with advanced solid tumors at a similar rate to traditional tumor biopsy, according to data presented at the ASCO Annual Meeting.In...
The results from a 'liquid biopsy' measuring circulating tumor DNA in blood matched up to these from conventional tissue biopsies. Medscape Medical News
Precision Biopsy announced that its application for an Investigational Device Exemption (IDE) was approved by the U.S. Food and Drug Administration (FDA), allowing the company to expand its clinical t...
(MedPage Today) -- To biopsy, or not to biopsy -- a Shakespearean dilemma
A large-scale genomic analysis finds that patterns of genetic changes detected in blood samples (liquid biopsy) closely mirror those identified in traditional tumour biopsy. With blood samples from m...
(MedPage Today) -- Brush plus standard biopsy shows promise in Barrett's esophagus
Which biopsy is more efficient in men with MR-visible prostate lesions? Targeted or standard? Journal of the National Cancer Institute
Roche Molecular Diagnostic's top researcher, Walter Koch, discusses the promise of liquid biopsy following FDA's recent approval of its first liquid-biopsy companion diagnostic, Roche's cobas test for...
Up to 70% of prostate biopsies are negative in men with suspected prostate cancer. Because of inherent limitations in biopsy strategies, a significant proportion of cancers are missed on initial biops...
The purpose of this study was to evaluate the prostate cancer yield rate of targeted transrectal ultrasound (TRUS)-guided biopsy with cognitive magnetic resonance imaging (MRI) registration without co...
To evaluate the cancer detection rates (CDR) for men undergoing 12 core systematic prostate biopsy with negative prebiopsy mpMRI (NegMR).
To minimize the sample variability of liver biopsy, the tissue length should be at least 25 mm. Consequently, more than one biopsy pass is needed with cutting biopsy needles. We aimed to investigate...
Sentinel lymph node (SLN) biopsy is now accepted as the standard of care for axillary staging in women with node-negative breast cancer. Currently, dye, radioisotope (RI), and fluorescence indocyanine...